Cargando…
Analysis of an Ebola virus disease survivor whose host and viral markers were predictive of death indicates the effectiveness of medical countermeasures and supportive care
BACKGROUND: Ebola virus disease (EVD) is an often-fatal infection where the effectiveness of medical countermeasures is uncertain. During the West African outbreak (2013–2016), several patients were treated with different types of anti-viral therapies including monoclonal antibody-based cocktails th...
Autores principales: | Bosworth, Andrew, Rickett, Natasha Y., Dong, Xiaofeng, Ng, Lisa F. P., García-Dorival, Isabel, Matthews, David A., Fletcher, Tom, Jacobs, Michael, Thomson, Emma C., Carroll, Miles W., Hiscox, Julian A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7798020/ https://www.ncbi.nlm.nih.gov/pubmed/33430949 http://dx.doi.org/10.1186/s13073-020-00811-9 |
Ejemplares similares
-
Variation around the dominant viral genome sequence contributes to viral load and outcome in patients with Ebola virus disease
por: Dong, Xiaofeng, et al.
Publicado: (2020) -
A comparison of host gene expression signatures associated with infection in vitro by the Makona and Ecran (Mayinga) variants of Ebola virus
por: Bosworth, Andrew, et al.
Publicado: (2017) -
Investigating the Cellular Transcriptomic Response Induced by the Makona Variant of Ebola Virus in Differentiated THP-1 Cells
por: Bosworth, Andrew, et al.
Publicado: (2019) -
Elucidating variations in the nucleotide sequence of Ebola virus associated with increasing pathogenicity
por: Dowall, Stuart D, et al.
Publicado: (2014) -
Transcriptomic signatures differentiate survival from fatal outcomes in humans infected with Ebola virus
por: Liu, Xuan, et al.
Publicado: (2017)